Cancer Biomarkers Market Is Expected To Reach $20958.63 Million By 2022 with Key Players - Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A.

Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by 2022 growing at a CAGR of 12.5% from 2015 to 2022. Technological improvements, huge investment flow for Research and Development and increasing usage in drug development and drug delivery are the factors driving the market growth. On the other hand, Sample collection and storage issue and poor reimbursement policies are hampering the market. Growing awareness for personalized medication is the opportunity for the market growth.

North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of increasing demand for non invasive diagnosis in this region. The diagnostics segment holds largest share in the market, followed by drug discovery and development.

FREE | Request sample copy @ http://www.reportsweb.com/inquiry&RW0001565009/sample

Some of the key players in the market include Abbott Laboratories, Becton Dickinson and Company, Correlogic Systems, Inc., Agilent Technologies, Biomerieux S.A., Astellas Pharma US Inc., Roche Diagnostics Corp., Astex Pharmaceuticals, Agendia Bv, Diadexus, Inc., Ambrilia Biopharma, CuraGen, Gen-Probe Inc, Beckman Coulter, Inc., Clarient, Inc, Biocurex Inc., and Aureon Laboratories, Inc.,

Services Covered:
- Biomakers validation and testing
- Sample preparation
- Assay development

Diseases Covered:
- Lung Cancer
- Cervical Cancer
- Prostate Cancer
- Colorectal Cancer
- Breast Cancer
- Other Cancers

Profiling Technologies Covered:
- Omics Technologies
o Transcriptomics
o Proteomics
§ Protein Microarray Technology
§ Peptide Array Technology
§ 2-D Gel Electrophoresis
§ Mass Spectrometry
- Imaging Mass Spectrometry
- Maldi Mass Spectrometry
§ Antibody Array Technology
o Genomics
§ Microarrays
§ Next Generation Sequencing (NGS)
§ PCR (Polymer Chain Reaction)
o Pharmacogenomics
o Metabolomics
- Bioinformatics
- IVD multivariate index assays
- Cytogenetics
o DNA microarrays
o Ish (In Situ Hybridization)
- Immunoassays
o Flow Cytometry
o Elisa
o Immunohistochemistry (IHC)
- Imaging Technologies
o Mammography
o Ultrasound
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT)
o Positron Emission Tomography (PET)

Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW0001565009/buying

Applications Covered:
- Risk Assessment
- Drug Discovery and Development
- Drug formulation
- Diagnostics
- Prognostics
- Other Applications

Types covered:
- Genetic Biomarkers
- Protein Biomarkers
- Other Types
o Carbohydrate biomarkers
o Cell biomarkers
o Viral biomarkers

About ReportsWeb:

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

This release was published on openPR.